Implantation technique and optimal subcutaneous defibrillator chest position: a PRAETORIAN score-based study.

Conversion Defibrillation test Implantable cardioverter defibrillator PRAETORIAN score Safety Subcutaneous Sudden death

Journal

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
ISSN: 1532-2092
Titre abrégé: Europace
Pays: England
ID NLM: 100883649

Informations de publication

Date de publication:
23 12 2020
Historique:
received: 15 06 2020
accepted: 16 07 2020
pubmed: 30 10 2020
medline: 29 6 2021
entrez: 29 10 2020
Statut: ppublish

Résumé

The traditional technique for subcutaneous implantable cardioverter-defibrillator (S-ICD) implantation involves three incisions and a subcutaneous pocket. Recently, a two-incision and intermuscular (IM) technique has been adopted. The PRAETORIAN score is a chest radiograph-based tool that predicts S-ICD conversion testing. We assessed whether the S-ICD implantation technique affects optimal position of the defibrillation system according to the PRAETORIAN score. We analysed consecutive patients undergoing S-ICD implantation. The χ2 test and regression analysis were used to determine the association between the PRAETORIAN score and implantation technique. Two hundred and thirteen patients were enrolled. The S-ICD generator was positioned in an IM pocket in 174 patients (81.7%) and the two-incision approach was adopted in 199 (93.4%). According to the PRAETORIAN score, the risk of conversion failure was classified as low in 198 patients (93.0%), intermediate in 13 (6.1%), and high in 2 (0.9%). Patients undergoing the two-incision and IM technique were more likely to have a low (<90) PRAETORIAN score than those undergoing the three-incision and subcutaneous technique (two-incision: 94.0% vs. three-incision: 78.6%; P = 0.004 and IM: 96.0% vs. subcutaneous: 79.5%; P = 0.001). Intermuscular plus two-incision technique was associated with a low-risk PRAETORIAN score (hazard ratio 3.76; 95% confidence interval 1.01-14.02; P = 0.04). Shock impedance was lower in PRAETORIAN low-risk patients than in intermediate-/high-risk categories (66 vs. 96 Ohm; P = 0.001). The PRAETORIAN score did not predict shock failure at 65 J. In this cohort of S-ICD recipients, combining the two-incision technique and IM generator implantation yielded the lowest PRAETORIAN score values, indicating optimal defibrillation system position. http://clinicaltrials.gov/ Identifier: NCT02275637.

Identifiants

pubmed: 33118017
pii: 5942720
doi: 10.1093/europace/euaa231
doi:

Banques de données

ClinicalTrials.gov
['NCT02275637']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1822-1829

Commentaires et corrections

Type : CommentIn
Type : ErratumIn

Informations de copyright

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2020. For permissions, please email: journals.permissions@oup.com.

Auteurs

Pietro Francia (P)

Division of Cardiology, Department of Clinical and Molecular Medicine, Sapienza University of Rome, St. Andrea Hospital, Via di Grottarossa, 1035, 00189 Rome, Italy.

Mauro Biffi (M)

Department of Experimental, Diagnostic and Specialty Medicine, Institute of Cardiology, University of Bologna, Policlinico S. Orsola-Malpighi, Bologna, Italy.

Carmen Adduci (C)

Division of Cardiology, Department of Clinical and Molecular Medicine, Sapienza University of Rome, St. Andrea Hospital, Via di Grottarossa, 1035, 00189 Rome, Italy.

Luca Ottaviano (L)

Istituto Clinico Sant'Ambrogio, Milan, Italy.

Federico Migliore (F)

Division of Cardiology, Department of Cardiac, Thoracic and Vascular Sciences, University of Padua, Padua, Italy.

Silvana De Bonis (S)

Division of Cardiology, Castrovillari Hospital, Cosenza, Italy.

Antonio Dello Russo (A)

Università Politecnica delle Marche, Ancona, Italy.

Paolo De Filippo (P)

Papa Giovanni XXIII Hospital, Bergamo, Italy.

Stefano Viani (S)

Second Cardiology Division, Cardio-Thoracic and Vascular Department, University Hospital of Pisa, Pisa, Italy.

Maria Grazia Bongiorni (MG)

Second Cardiology Division, Cardio-Thoracic and Vascular Department, University Hospital of Pisa, Pisa, Italy.

Fabrizio Caravati (F)

Division of Cardiology, 'Circolo e Fondazione Macchi' Hospital, Varese, Italy.

Carlo Lavalle (C)

Policlinico Umberto I-'Sapienza' University of Rome, Rome, Italy.

Maurizio Eugenio Landolina (ME)

Division of Cardiology, 'Maggiore' Hospital of Crema, Cremona, Italy.

Ennio Pisanò (E)

'Vito Fazzi' Hospital-Lecce, Lecce, Italy.

Davide Giorgi (D)

Division of Cardiology, 'San Luca' Hospital, Lucca, Italy.

Mariolina Lovecchio (M)

Boston Scientific, Milan, Italy.

Sergio Valsecchi (S)

Boston Scientific, Milan, Italy.

Igor Diemberger (I)

Department of Experimental, Diagnostic and Specialty Medicine, Institute of Cardiology, University of Bologna, Policlinico S. Orsola-Malpighi, Bologna, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH